Picture of Innocan Pharma logo

INNO Innocan Pharma Balance Sheet

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Innocan Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:
Source:PROSPECTUSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments0.2141.972.34114.95
Net Total Accounts Receivable
Net Total Receivables0.0720.0571.130.1690.243
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets0.6572.494.2812.56.88
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.0030.0950.0560.0540.098
Total Assets0.662.584.3312.66.98
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities0.4731.137.943.560.731
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities0.5331.177.943.520.582
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity0.1271.41-3.619.056.39
Total Liabilities & Shareholders' Equity0.662.584.3312.66.98
Total Common Shares Outstanding